Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline in non-ischemic cardiomyopathy
NCT01935622Phase 2Terminated
- Sponsor
- Virginia Commonwealth University
- Start
- Jul 2012
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of doxycycline in Non-Ischaemic Cardiomyopathy (NICM), sponsored by Virginia Commonwealth University. Primary endpoint: Peak Aerobic Exercise Capacity at 14 days. Started Jul 2012; status: terminated.
02
Drugs
doxycycline
03
Conditions
Non-Ischaemic Cardiomyopathy (NICM)
Beyond the preview
Go deeper on NCT01935622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01935622.